The Biden Administration has proposed new regulations on short-term, limited-duration health insurance plans, undoing a policy implemented by the previous Administration. The proposed rule would limit the duration of short-term policies to three months and disallow a consumer’s reenrollment into the same plan (Modern Healthcare, July 7).
Under a proposed rule, CMS is planning to make a one-time, lump sum payment of $9 billion to 340B hospitals to compensate for the loss in 340B drug reimbursements that the Supreme Court considered unlawful (Inside Health Policy, July 7; Politico, July 7).
On July 6, the FDA approved the Alzheimer’s drug Leqembi, marking a significant move that makes the treatment more widely available and accessible to Medicare patients (Inside Health Policy, July 11).
From July 5 to July 12, CMS approved 5 SPAs, 1 of which was a COVID-19 disaster relief SPA.